INS and lung carcinoma: Verteporfin has been demonstrated to effectively restrain the proliferation and migration of lung cancer cells through the modulation of the Hippo signaling pathway and insulin secretion with the experimental evidence of in vitro cytotoxicity and apoptosis assays and in vivo xenograft models (Figure 6B) (62).